| At baseline | After 52-week treatment period | ||||
---|---|---|---|---|---|---|
COMT Val108/158Met genotype (number of patients) | AA (39) | AG (101) | GG (45) | AA (39) | AG (101) | GG (45) |
BMI (kg/m2) | 29.41 (22.59–37.8) | 30.02 (20.66–47.80) | 30.04 (20.98–52.6) | 29.28 (23.84–37.78) | 30.10 (22.55–45.17) | 29.39 (22.92–47.26) |
Kruskal–Wallis ANOVA on Ranks | H = 0.137; df = 2; p = 0.934 | H = 0.067; df = 2; p = 0.967 | ||||
Body weight (kg) | 85.00 (63.00–106.00) | 82.00 (54.00–127.00) | 84.00 (59.00–128.00) | 84.00 (64.00–108.00) | 83.00 (55.00–120.00) | 82.00 (59.00–115.00) |
Kruskal–Wallis ANOVA on ranks | H = 0.662; df = 2; p = 0.719 | H = 0.167; df = 2; p = 0.920 | ||||
Fasting glucose levels (mmol/L) | 12.30 (7.00–18.90) | 11.00 (5.20–19.70) | 11.70 (8.20–21.30) | 8.40 (4.40–17.70) | 8.10 (4.60–15.90) | 8.10 (5.40–14.50) |
Kruskal–Wallis ANOVA on ranks | H = 2.116; df = 2; p = 0.347 | H = 0.397; df = 2; p = 0.820 | ||||
HbA1c | 8.4 (7.00–11.20) | 8.4 (6.20–11.80) | 8.5 (7.20–12.80) | 7.7 (6.20–10.20) | 7.6 (5.10–10.5) | 8.00 (5.80–11.90) |
Kruskal–Wallis ANOVA on ranks | H = 2.684; df = 2; p = 0.261 | H = 4.965; df = 2; p = 0.084 | ||||
 | At baseline | After 52-week treatment period | ||||
DBH-1021C/T genotype (number of patients) | CC (113) | CT (64) | TT (8) | CC (113) | CT (64) | TT (8) |
BMI (kg/m2) | 29.88 (20.66–47.80) | 30.04 (22.19–52.60) | 34.26 (26.47–35.51) | 30.10 (22.55–45.17) | 29.40 (22.60–47.26) | 30.86 (27.14–34.26) |
Kruskal–Wallis ANOVA on ranks | H = 1.426; df = 2; p = 0.490 | H = 1.018; df = 2; p = 0.601 | ||||
Body weight (kg) | 82.00 (58.00–127.00) | 84.50 (54.00–128.00) | 89.00 (72.00–110.00) | 82.00 (57.00–120.00) | 83.50 (55.00–115.00) | 87.00 (72.00–106.00) |
Kruskal–Wallis ANOVA on ranks | H = 1.279; df = 2; p = 0.527 | H = 1.403; df = 2; p = 0.498 | ||||
Fasting glucose levels | 11.10 (5.20–20.10) | 11.5 (7.10–21.30) | 11.9 (9.10–12.80) | 8.25 (5.20–15.90) | 8.25 (4.40–17.70) | 7.10 (6.20–11,10) |
Kruskal–Wallis ANOVA on ranks | H = 1.073; df = 2; p = 0.585 | H = 0.373; df = 2; p = 0.830 | ||||
HbA1c | 8.50 (6.50–12.80) | 8.40 (6.20–11.80) | 8.65 (7.80–10.20) | 7.70 (5.90–11.90) | 7.8 (5.10–10.30) | 7.7 (6.20–8.60) |
Kruskal–Wallis ANOVA on ranks | H = 0.612; df = 2; p = 0.736 | H = 0.302; df = 2; p = 0.860 |